financetom
Personal Finance
financetom
/
Personal Finance
/
Research Alert: CFRA Maintains Buy Opinion On Wns (holdings) Limited
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Research Alert: CFRA Maintains Buy Opinion On Wns (holdings) Limited
May 1, 2024 5:59 AM

08:35 AM EDT, 05/01/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

WNS printed Mar-Q adj-EPS of $1.12 vs. $1.04 a year ago, beating consensus by $0.06. Revenues (less repair payments) were$326M, +7% Y/Y, as increases in new clients (nine in Mar-Q) and broadening existing client relationships (40) were partially tampered with by transitioning a large internet client's work offshore, in addition to volume reductions with certain clients. Adj-operating margins expanded to 21.5% from 20.6% Y/Y. Despite challenging economic conditions, our rating remains Buy as we believe more companies will be looking to cut costs, playing into WNS's strengths. An improving pipeline positions WNS for outsized growth as demand for business transformation that leverages digital and analytics capabilities increases. We see adj-revenue of $1.35B (+5%) in FY 2025 (Mar-Q) and $1.49B (+10%) in FY 2026. Our 12-month target of $57 (down $23), 11.2x our FY 2026 (Mar-Q) EPS, is aligned with three-year historical averages. We lower our FY 2025 EPS view to $4.56 from $4.71 and initiate FY 2026's at $5.08.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Research Alert: CFRA Keeps Hold Opinion On Adss Of Novo Nordisk
Research Alert: CFRA Keeps Hold Opinion On Adss Of Novo Nordisk
Aug 22, 2025
06:10 AM EDT, 08/22/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We adjust our target price to USD61 from USD49 implying 15.6x our 2025 EPADS, a discount to its historical forward P/E average of 25x-31x, justified in our view to reflect...
Research Alert: CFRA Maintains Hold Opinion On Shares Of Bilibili Inc.
Research Alert: CFRA Maintains Hold Opinion On Shares Of Bilibili Inc.
Aug 22, 2025
08:30 AM EDT, 08/22/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: ...
Research Alert: CFRA Maintains Buy Opinion On Shares Of Aegon
Research Alert: CFRA Maintains Buy Opinion On Shares Of Aegon
Aug 21, 2025
05:50 AM EDT, 08/21/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We raise our target price to USD9.50 (from USD7.90), based on a 2025 P/BV of 1.7x, which reflects a 35% discount to peer average of 2.6x. Aegon's ( AEG )...
Research Alert: CFRA Lifts Opinion On Shares Of Walmart Inc. To Strong Buy From Buy
Research Alert: CFRA Lifts Opinion On Shares Of Walmart Inc. To Strong Buy From Buy
Aug 21, 2025
01:45 PM EDT, 08/21/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We lift our 12-month target by $2 to $120, about 40x our FY 27 (Jan.) EPS of $2.99 (from $2.94; FY 26 to $2.68 from $2.66), a justifiable premium to...
Copyright 2023-2026 - www.financetom.com All Rights Reserved